Journey Medical (DERM)
(Delayed Data from NSDQ)
$6.99 USD
-0.36 (-4.90%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $6.99 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Journey Medical Corporation has a market cap of $171.22M, which represents its share price of $7.35 multiplied by its outstanding shares number of 23.30M. As a small-cap company, DERM's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
DERM 6.99 -0.36(-4.90%)
Will DERM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DERM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DERM
Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates
Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates
DERM: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Joint Corp. (JYNT) Reports Q1 Loss, Tops Revenue Estimates
Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Lags Revenue Estimates
Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength?
Other News for DERM
DERM: B. Riley Securities Raises Price Target for Journey Medical | DERM Stock News
New Price Target for Journey Medical (DERM)
Journey Medical price target raised by $3 at B. Riley, here's why
DERM Expands Coverage for Rosacea Treatment Emrosi | DERM Stock News